3Cleeman JI. Executive summary of the third repot of the national cholesterol education program (NCEP)expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ)[J].JA MA,2001,285:2486.
4Chong PH, Seeger JD, Franldin C. Clinically relevent differences between the statins: implications for therapeutic selection[J ]. Am J Med,2001, 111:390.
5Maron DJ, Fazio S, Linton MF. Current perspectives on stafins[J ]. Circulation,2000,101:207.
6Plenge JK, Hemandez TL, Well KM, et al. Simvastatin lowers creactive protein within 14 days An effect independent of lowdensity lipoprotein cholestero reduction[J ]. Circulation, 2002,106:1447.
7Scandinavian Simvastatin Survival Study Group. Randomised trial of cholestrol lowering in 4 444 patients with coronary heart disease: the scandiwavian simvastatin survival stuay ( 4 s) [ J ].Lancet, 1994,344:1383.
8Heart Protection Study Collborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals;a randomised plaeebo-controlled trial[J]. Lancet ,2002,306:7.
9Pedersen TR, Berg K, Cook TJ, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 year in the scandinavian simvastatin survival study[J ]. Arch Intern Med, 1996,156:2085.
10Pedersen TR, Willmlmsen L, Faergeman O, et al. Follow-up study of patientis randomized in the scandinavian simvastatin survival study (4 s) of cholesterol lowerlng[J]. Am J Cardiol,2000,86:257.
